KCM
VRNA

Knoll Capital Management’s Verona Pharma VRNA Stock Holding History

Knoll Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,049
Closed -$667K – 41
2025
Q2 		$667K Hold
7,049
– – 0.47% 31
2025
Q1 		$448K Sell
7,049
-192,951
-96% -$11.5M 0.29% 34
2024
Q4 		$9.29M Hold
200,000
– – 5.98% 4
2024
Q3 		$5.75M Hold
200,000
– – 2.67% 10
2024
Q2 		$2.89M Hold
200,000
– – 1.95% 16
2024
Q1 		$3.22M Hold
200,000
– – 2% 12
2023
Q4 		$3.98M Hold
200,000
– – 3.29% 7
2023
Q3 		$3.26M Hold
200,000
– – 3.38% 6
2023
Q2 		$4.23M Hold
200,000
– – 5.13% 6
2023
Q1 		$4.02M Buy
200,000
+104,609
+110% +$2.26M 6.19% 4
2022
Q4 		$2.49M Buy
+95,391
New +$1.27M 5.63% 6

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Knoll Capital Management's VRNA Position: Q3 2025 in Review

Knoll Capital Management sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 7,049 shares — an estimated $667K sold.

Knoll Capital Management first reported a position in VRNA in Q4 2022 and held it in 11 quarters. The position peaked at $9.29M in Q4 2024. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • Knoll Capital Management reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • Knoll Capital Management sold 7,049 Verona Pharma shares in Q3 2025, an estimated $667K.
  • Knoll Capital Management first reported a position in Verona Pharma in Q4 2022 and held it in 11 quarters.
  • Knoll Capital Management's Verona Pharma position peaked at $9.29M in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Knoll Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.